Yatin Suneja
Stock Analyst at Guggenheim
(4.70)
# 134
Out of 5,169 analysts
161
Total ratings
59.59%
Success rate
27.61%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBIO Zenas BioPharma | Maintains: Buy | $45 → $55 | $22.92 | +139.97% | 4 | Mar 17, 2026 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $60 | $41.07 | +46.09% | 2 | Mar 13, 2026 | |
| ACET Adicet Bio | Maintains: Buy | $128 → $100 | $6.95 | +1,338.85% | 4 | Mar 13, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $100 → $200 | $79.93 | +150.23% | 3 | Mar 4, 2026 | |
| SION Sionna Therapeutics | Maintains: Buy | $45 → $50 | $34.55 | +44.72% | 1 | Mar 3, 2026 | |
| PHAT Phathom Pharmaceuticals | Maintains: Buy | $20 → $25 | $10.94 | +128.52% | 5 | Feb 27, 2026 | |
| ARGX argenx SE | Maintains: Buy | $1,160 → $1,120 | $692.16 | +61.81% | 14 | Feb 27, 2026 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $205 → $220 | $158.14 | +39.12% | 10 | Feb 24, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $760 → $800 | $297.54 | +168.87% | 5 | Feb 10, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $865 → $975 | $737.00 | +32.29% | 9 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $246 | $180.89 | +35.99% | 4 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $27.71 | +8.26% | 4 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $44 | $24.19 | +81.89% | 9 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $14.96 | +234.22% | 1 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $32 | $25.00 | +28.00% | 3 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.90 | +284.62% | 1 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $51 | $19.68 | +159.15% | 2 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $22 | $1.00 | +2,100.00% | 6 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $100 | $65.08 | +53.66% | 14 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $14 | $2.73 | +412.82% | 3 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $150 | $123.48 | +21.48% | 3 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $20 | $16.68 | +19.90% | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $25.73 | +191.55% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $2.88 | +420.83% | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $175 | $129.75 | +34.88% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $4.31 | +503.25% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $29 | $15.22 | +90.54% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $6.15 | +143.90% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $25.53 | +76.26% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $20.29 | -1.43% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.72 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $42.90 | +51.52% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $28.79 | +212.61% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.68 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $53.96 | -9.19% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $13.78 | +299.13% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.38 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $16.75 | +43.33% | 1 | May 31, 2022 |
Zenas BioPharma
Mar 17, 2026
Maintains: Buy
Price Target: $45 → $55
Current: $22.92
Upside: +139.97%
Oruka Therapeutics
Mar 13, 2026
Reiterates: Buy
Price Target: $60
Current: $41.07
Upside: +46.09%
Adicet Bio
Mar 13, 2026
Maintains: Buy
Price Target: $128 → $100
Current: $6.95
Upside: +1,338.85%
Dianthus Therapeutics
Mar 4, 2026
Maintains: Buy
Price Target: $100 → $200
Current: $79.93
Upside: +150.23%
Sionna Therapeutics
Mar 3, 2026
Maintains: Buy
Price Target: $45 → $50
Current: $34.55
Upside: +44.72%
Phathom Pharmaceuticals
Feb 27, 2026
Maintains: Buy
Price Target: $20 → $25
Current: $10.94
Upside: +128.52%
argenx SE
Feb 27, 2026
Maintains: Buy
Price Target: $1,160 → $1,120
Current: $692.16
Upside: +61.81%
Axsome Therapeutics
Feb 24, 2026
Maintains: Buy
Price Target: $205 → $220
Current: $158.14
Upside: +39.12%
Praxis Precision Medicines
Feb 10, 2026
Maintains: Buy
Price Target: $760 → $800
Current: $297.54
Upside: +168.87%
Regeneron Pharmaceuticals
Feb 9, 2026
Maintains: Buy
Price Target: $865 → $975
Current: $737.00
Upside: +32.29%
Feb 9, 2026
Maintains: Buy
Price Target: $185 → $246
Current: $180.89
Upside: +35.99%
Feb 9, 2026
Maintains: Buy
Price Target: $28 → $30
Current: $27.71
Upside: +8.26%
Feb 9, 2026
Maintains: Buy
Price Target: $41 → $44
Current: $24.19
Upside: +81.89%
Feb 2, 2026
Initiates: Buy
Price Target: $50
Current: $14.96
Upside: +234.22%
Jan 7, 2026
Maintains: Buy
Price Target: $18 → $32
Current: $25.00
Upside: +28.00%
Dec 19, 2025
Initiates: Buy
Price Target: $15
Current: $3.90
Upside: +284.62%
Dec 17, 2025
Maintains: Buy
Price Target: $35 → $51
Current: $19.68
Upside: +159.15%
Nov 10, 2025
Maintains: Buy
Price Target: $10 → $22
Current: $1.00
Upside: +2,100.00%
Nov 5, 2025
Maintains: Buy
Price Target: $90 → $100
Current: $65.08
Upside: +53.66%
Oct 27, 2025
Upgrades: Buy
Price Target: $14
Current: $2.73
Upside: +412.82%
Oct 10, 2025
Maintains: Buy
Price Target: $101 → $150
Current: $123.48
Upside: +21.48%
Sep 30, 2025
Maintains: Buy
Price Target: $80 → $20
Current: $16.68
Upside: +19.90%
Aug 18, 2025
Initiates: Buy
Price Target: $75
Current: $25.73
Upside: +191.55%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.88
Upside: +420.83%
Aug 1, 2025
Maintains: Buy
Price Target: $165 → $175
Current: $129.75
Upside: +34.88%
Jun 25, 2025
Reiterates: Buy
Price Target: $26
Current: $4.31
Upside: +503.25%
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $15.22
Upside: +90.54%
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $6.15
Upside: +143.90%
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $25.53
Upside: +76.26%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $20.29
Upside: -1.43%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.72
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $42.90
Upside: +51.52%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $28.79
Upside: +212.61%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.68
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $53.96
Upside: -9.19%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $13.78
Upside: +299.13%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $6.38
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $16.75
Upside: +43.33%